U.S. flag

An official website of the United States government

NM_000238.4(KCNH2):c.1814C>T (p.Pro605Leu) AND Long QT syndrome 2

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Oct 19, 2020
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000735254.4

Allele description [Variation Report for NM_000238.4(KCNH2):c.1814C>T (p.Pro605Leu)]

NM_000238.4(KCNH2):c.1814C>T (p.Pro605Leu)

Gene:
KCNH2:potassium voltage-gated channel subfamily H member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q36.1
Genomic location:
Preferred name:
NM_000238.4(KCNH2):c.1814C>T (p.Pro605Leu)
HGVS:
  • NC_000007.14:g.150951579G>A
  • NG_008916.1:g.31348C>T
  • NM_000238.4:c.1814C>TMANE SELECT
  • NM_001204798.2:c.794C>T
  • NM_001406753.1:c.1526C>T
  • NM_001406755.1:c.1637C>T
  • NM_001406756.1:c.1526C>T
  • NM_001406757.1:c.1514C>T
  • NM_172056.3:c.1814C>T
  • NM_172057.3:c.794C>T
  • NP_000229.1:p.Pro605Leu
  • NP_000229.1:p.Pro605Leu
  • NP_001191727.1:p.Pro265Leu
  • NP_001393682.1:p.Pro509Leu
  • NP_001393684.1:p.Pro546Leu
  • NP_001393685.1:p.Pro509Leu
  • NP_001393686.1:p.Pro505Leu
  • NP_742053.1:p.Pro605Leu
  • NP_742053.1:p.Pro605Leu
  • NP_742054.1:p.Pro265Leu
  • NP_742054.1:p.Pro265Leu
  • LRG_288t1:c.1814C>T
  • LRG_288t2:c.1814C>T
  • LRG_288t3:c.794C>T
  • LRG_288:g.31348C>T
  • LRG_288p1:p.Pro605Leu
  • LRG_288p2:p.Pro605Leu
  • LRG_288p3:p.Pro265Leu
  • NC_000007.13:g.150648667G>A
  • NM_000238.3:c.1814C>T
  • NM_172056.2:c.1814C>T
  • NM_172057.2:c.794C>T
  • NR_176254.1:n.2222C>T
  • NR_176255.1:n.1095C>T
  • Q12809:p.Pro605Leu
Protein change:
P265L
Links:
UniProtKB: Q12809#VAR_074844; dbSNP: rs199472938
NCBI 1000 Genomes Browser:
rs199472938
Molecular consequence:
  • NM_000238.4:c.1814C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001204798.2:c.794C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406753.1:c.1526C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406755.1:c.1637C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406756.1:c.1526C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406757.1:c.1514C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172056.3:c.1814C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172057.3:c.794C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Long QT syndrome 2 (LQT2)
Identifiers:
MONDO: MONDO:0013367; MedGen: C3150943; Orphanet: 101016; Orphanet: 768; OMIM: 613688

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000863463Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 11, 2018)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002767863Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 19, 2020)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The dominant negative LQT2 mutation A561V reduces wild-type HERG expression.

Kagan A, Yu Z, Fishman GI, McDonald TV.

J Biol Chem. 2000 Apr 14;275(15):11241-8.

PubMed [citation]
PMID:
10753933

Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.

Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ.

Heart Rhythm. 2009 Sep;6(9):1297-303. doi: 10.1016/j.hrthm.2009.05.021. Epub 2009 Jun 23.

PubMed [citation]
PMID:
19716085
PMCID:
PMC3049907
See all PubMed Citations (7)

Details of each submission

From Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues, SCV000863463.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV002767863.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as Likely pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with Long QT syndrome 2 (MIM#613688). Gain of function is also a known mechanism associated with Short QT syndrome 1 (MIM#609620) (OMIM, PMID: 10753933; PMID: 21777565). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance (PMID: 20301308). (I) 0200 - Variant is predicted to result in a missense amino acid change from proline to leucine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated pore region (PMID: 21956039). (I) 0704 - Another two missense variants comparable to the one identified in this case has limited previous evidence for pathogenicity. A different amino acid change to serine at the same position has been reported in a patient with Long QT syndrome 2 (ClinVar, PMID: 19716085). Additionally another change to histidine at the same position has been reported as VUS in ClinVar. (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. The variant has been previously reported in patients with Long QT syndrome (ClinVar, PMID: 19716085, 21956039). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Functional studies using HEK293 cells show that this variant leads to deficient trafficking (PMID: 25417810). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024